18889881171
Kalkine 0
countryflagUS
Login

AAPL 202.822 2.3578% MSFT 385.065 -0.8714% NVDA 110.62 -0.2795% GOOGL 158.07 0.5918% GOOG 160.595 0.7497% AMZN 180.12 -2.5694% META 530.4817 -2.4078% AVGO 177.435 -2.4761% LLY 746.49 1.9224% TSLA 247.19 -2.0292% TSM 155.22 -1.1841% V 334.03 0.189% JPM 234.86 -0.5673% UNH 580.66 -3.1378% NVO 65.6 1.344% WMT 94.01 1.3039% LVMUY 113.56 -6.3423% XOM 103.755 0.5963% LVMHF 580.0 -4.0577% MA 510.595 0.1658%
AAPL 202.822 2.3578% MSFT 385.065 -0.8714% NVDA 110.62 -0.2795% GOOGL 158.07 0.5918% GOOG 160.595 0.7497% AMZN 180.12 -2.5694% META 530.4817 -2.4078% AVGO 177.435 -2.4761% LLY 746.49 1.9224% TSLA 247.19 -2.0292% TSM 155.22 -1.1841% V 334.03 0.189% JPM 234.86 -0.5673% UNH 580.66 -3.1378% NVO 65.6 1.344% WMT 94.01 1.3039% LVMUY 113.56 -6.3423% XOM 103.755 0.5963% LVMHF 580.0 -4.0577% MA 510.595 0.1658%

Adtalem Global Education Inc

Consumer Defensive US ATGE

103.445USD
-0.335(0.32%)

Last update at 2025-04-14T16:38:00Z

Day Range

102.14105.62
LowHigh

52 Week Range

43.7792.93
LowHigh

Fundamentals

  • Previous Close 103.78
  • Market Cap3296.19M
  • Volume146988
  • P/E Ratio20.35
  • Dividend Yield-%
  • EBITDA396.25M
  • Revenue TTM1633.21M
  • Revenue Per Share TTM42.43
  • Gross Profit TTM 802.34M
  • Diluted EPS TTM4.32

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

2019-06-302020-06-302021-06-302022-06-302023-06-300M200M400M600M800M1000M1200M1400M
Total Revenue
Net Income

Balancesheet

2020-06-302021-06-302022-06-302023-06-302024-06-300M200M400M600M800M1000M1200M1400M1600M1800M2000M2200M2400M2600M2800M3000M
Total Assets
Total Liabilities

Change in Cash

2020-06-302021-06-302022-06-302023-06-302024-06-30-800M-600M-400M-200M0M200M400M600M800M

Total Operating Cash

2020-06-302021-06-302022-06-302023-06-302024-06-300M20M40M60M80M100M120M140M160M180M200M220M240M260M280M300M

Dividends Paid

2020-06-302021-06-302022-06-302023-06-302024-06-300M1M2M3M4M5M6M7M8M9M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax 112.03M -45.06400M 126.85M 237.18M 170.18M
Minority interest 0.00000M 0.00000M 1.79M 2.85M 0.41M
Net income 93.36M -29.82700M 76.91M 243.54M 136.02M
Selling general administrative 586.01M 568.06M 420.27M 395.84M 400.41M
Selling and marketing expenses - - - - -
Gross profit 802.34M 727.35M 623.15M 561.95M 616.15M
Reconciled depreciation 151.28M 186.60M 99.05M 100.97M 51.74M
Ebit 223.28M 163.11M 161.48M 142.26M 185.99M
Ebitda 374.56M 349.71M 306.02M 270.77M 275.45M
Depreciation and amortization 151.28M 186.60M 144.54M 128.51M 89.46M
Non operating income net other 6.96M -125.52800M -34.63300M 99.70M -
Operating income 168.17M 163.11M 161.48M 142.26M 185.99M
Other operating expenses 1234.49M 1227.83M 909.50M 885.89M 1023.95M
Interest expense 63.16M 129.35M 41.37M 19.51M 23.63M
Tax provision 10.28M -15.23700M 25.25M -6.35800M 34.16M
Interest income - 3.82M 4.09M 3.69M 7.98M
Net interest income -63.17100M -123.07500M -37.27100M -15.82200M -15.65500M
Extraordinary items - - - - -44.02700M
Non recurring 48.16M 78.83M 41.40M 28.63M 55.92M
Other items - - - - -
Income tax expense 10.28M -15.23700M 25.25M -6.35800M 34.16M
Total revenue 1450.83M 1387.12M 1112.38M 1052.00M 1239.69M
Total operating expenses 586.01M 568.06M 420.27M 395.84M 400.41M
Cost of revenue 648.49M 659.78M 489.23M 490.05M 623.54M
Total other income expense net -41.12500M -208.17400M -34.63300M 94.92M -15.80800M
Discontinued operations -8.39400M 347.53M -25.12700M -329.31500M -40.44300M
Net income from continuing ops 101.75M -29.82700M 101.60M 243.54M 136.02M
Net income applicable to common shares 93.36M 317.70M 76.91M -85.33400M 95.17M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 2741.42M 2810.54M 3029.18M 3053.84M 2228.69M
Intangible assets 776.69M 812.34M 873.58M 276.25M 287.51M
Earning assets - - - - -
Other current assets 71.95M 100.72M 127.43M 952.34M 96.24M
Total liab 1372.28M 1353.20M 1524.11M 1750.98M 915.41M
Total stockholder equity 1369.13M 1457.34M 1505.07M 1301.07M 1310.42M
Deferred long term liab - 26.07M 25.55M 1.50M 1.52M
Other current liab 202.43M 157.85M 164.77M 193.71M 153.27M
Common stock 0.83M 0.82M 0.82M 0.81M 0.81M
Capital stock 0.83M 0.82M 0.82M 0.81M 0.81M
Retained earnings 2540.51M 2403.75M 2322.81M 2005.11M 1927.57M
Other liab - 63.48M 90.63M 106.60M 107.28M
Good will 961.26M 961.26M 961.26M 686.37M 686.21M
Other assets - 125.20M 170.38M 110.08M 101.16M
Cash 219.31M 273.69M 346.97M 494.61M 500.52M
Cash and equivalents - - - - -
Total current liabilities 487.66M 431.20M 417.53M 408.81M 345.98M
Current deferred revenue 185.27M 153.87M 144.84M 100.70M 91.59M
Net debt 628.55M 622.50M 719.76M 799.28M 16.27M
Short term debt 62.86M 37.67M 50.78M 58.33M 54.64M
Short long term debt - - - 3.00M 3.00M
Short long term debt total 847.85M 896.19M 1066.73M 1293.89M 516.79M
Other stockholder equity -1169.97900M -945.00900M -817.60100M -697.48100M -608.89900M
Property plant equipment - 258.52M 289.93M 466.18M 461.04M
Total current assets 418.08M 478.54M 556.04M 1514.95M 692.77M
Long term investments - - - - -
Net tangible assets - -316.26400M -329.77200M 338.45M 336.69M
Short term investments 13.20M - - - 8.97M
Net receivables 126.83M 102.75M 81.64M 68.00M 87.04M
Long term debt 648.71M 695.08M 838.91M 1067.71M 286.12M
Inventory 0.00000M 1.39M - - -
Accounts payable 102.63M 81.81M 57.14M 56.07M 46.48M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 1.79M 2.85M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2.22700M -2.22700M -0.96000M -7.36500M -9.05500M
Additional paid in capital - - - - -
Common stock total equity - 0.82M 0.82M 0.81M 0.81M
Preferred stock total equity - - - - -
Retained earnings total equity - 2403.75M 2322.81M 2005.11M 1927.57M
Treasury stock - - - -1217.30700M -1113.33300M
Accumulated amortization - - - - -
Non currrent assets other 111.01M 68.51M 119.28M 87.60M 78.88M
Deferred long term asset charges - - - - -
Non current assets total 2323.33M 2332.00M 2473.14M 1538.88M 1535.92M
Capital lease obligations 199.14M 201.11M 227.83M 223.18M 227.68M
Long term debt total - 695.08M 838.91M 1067.71M 286.12M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments -47.85000M 52.93M 10.00M -8.02400M 110.54M
Change to liabilities - 12.03M 19.78M 17.64M -10.99900M
Total cashflows from investing activities - 12.74M -551.62700M -56.68800M 382.52M
Net borrowings - -164.02300M -309.26600M 797.00M -107.80000M
Total cash from financing activities -301.79800M -288.51500M -424.47600M 676.47M -256.10900M
Change to operating activities - -82.85100M -105.70500M -38.37500M -86.64100M
Net income 137.71M 101.75M -29.82700M 101.60M 243.54M
Change in cash -53.87300M -72.86200M -965.67900M 812.51M 200.64M
Begin period cash flow 275.07M 347.94M 1313.62M 501.11M 300.47M
End period cash flow 221.20M 275.07M 347.94M 1313.62M 501.11M
Total cash from operating activities 295.77M 202.91M 10.42M 192.20M 107.69M
Issuance of capital stock - - - - -
Depreciation 107.96M 151.28M 186.60M 99.05M 100.97M
Other cashflows from investing activities - -3.17400M -530.57300M -8.78300M 316.12M
Dividends paid - 3.23M 9.41M 1.72M 3.78M
Change to inventory - -65.30600M - -22.62900M -71.64200M
Change to account receivables -76.35500M -37.61400M -29.88100M 13.26M -12.84000M
Sale purchase of stock -261.96600M -123.13300M -120.00000M -100.00000M -136.88900M
Other cashflows from financing activities 10.17M -14.52100M -74.76300M -20.53400M 218.78M
Change to netincome - -3.26300M -133.40600M 21.49M -131.20500M
Capital expenditures 48.89M 37.01M 31.05M 48.66M 44.14M
Change receivables - -37.61400M -29.88100M 13.26M -12.84000M
Cash flows other operating - 119.81M -30.56900M 82.58M 216.48M
Exchange rate changes - - - - -
Cash and cash equivalents changes - -72.86200M -965.67900M 811.98M 234.11M
Change in working capital -52.91300M -92.99200M -86.23500M -7.47800M -110.17600M
Stock based compensation 25.95M 14.30M 22.61M 12.82M 13.88M
Other non cash items 65.99M 33.65M -82.17700M -16.37000M -136.67700M
Free cash flow 246.88M 165.90M -20.63000M 143.53M 63.55M

Peer Comparison

Sector: Consumer Defensive Industry: Education & Training Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ATGE
Adtalem Global Education Inc		 -0.335 0.32% 103.44 20.35 13.53 2.02 2.46 2.45 11.14
EDU
New Oriental Education & Technology		 1.25 2.92% 44.28 47.29 27.70 4.11 3.19 2.81 21.59
TAL
TAL Education Group		 0.47 4.84% 10.06 - 56.50 6.54 2.16 4.19 -40.7835
LOPE
Grand Canyon Education Inc		 -0.33 0.19% 172.07 20.34 17.09 4.08 5.46 3.93 12.95
IDPUF
IDP Education Limited		 - -% 7.62 42.72 34.01 4.36 12.36 3.87 14.16

Reports Covered

Stock Research & News

View All

Profile

Adtalem Global Education Inc. engages in the provision of workforce solutions worldwide. It operates through three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees, as well as online certificates in the medical, nursing, health professions and veterinary postsecondary education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice industries. It operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as DeVry Education Group Inc. and changed its name to Adtalem Global Education Inc. in May 2017. Adtalem Global Education Inc. was incorporated in 1987 and is based in Chicago, Illinois.

Adtalem Global Education Inc

500 West Monroe Street, Chicago, IL, United States, 60661

Key Executives

Name Title Year Born
Mr. Stephen W. Beard Pres, CEO & Director 1971
Mr. Robert J. Phelan Sr. VP & CFO 1966
Mr. Douglas G. Beck Sr. VP, Gen. Counsel & Corp. Sec. 1967
Mr. Maurice Herrera Sr. VP & Chief Marketing Officer 1970
Mr. John W. Danaher M.D. Pres of Medical & Veterinary 1959
Dr. Heidi Chumley M.D., MBA Exec. Dean NA
Dr. Sean Callanan MVB, MRCVS, CertVR, Ph.D., DipECVP, FRCPath Dean NA
Dr. William F. Owen Jr. Dean & Chancellor - Ross University School of Medicine 1956
Mr. Manjunath Gangadharan VP & Chief Accounting Officer 1983
Chandrika Nigam Sr. Director of Investor Relations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.